2,701
+2.62%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medikit Co
Its shares trade on Tokyo Stock Exchange under the ticker 7749.T. It has been listed since 1 June 2005. In the fiscal year to 31 March 2026, it reported revenue of ¥23.78bn and net income of ¥3.01bn. At that date it held total assets of ¥53.27bn and shareholders' equity of ¥46.78bn.
Medikit Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Bunkyo-Ku, Tokyo-To. The company went IPO on 2005-06-01. Its major products consist of artificial diagnostic equipment, which includes indwelling needles that are used for artificial dialysis purposes; indwelling venous needles (anesthesia type), which are used for blood and fluid transfusion purposes, and angiography equipment, which includes introducers and angiographic catheters.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Jun 2005
- Employees
- 968
- Website
- medikit.co.jp ↗
Leadership
Pay as last reported
- Mr. Yoji KageyamaPresident, Representative Director, since 2007
- Mr. Takashi NakajimaVice President, President of Subsidiary, Director, since 2010
- Mr. Takashi HodatsuExecutive Officer, Director of West Japan Sales
- Mr. Hajime TobitaExecutive Officer, Director of East Japan Sales, Director Incharge of Dialysis Business of Marketing Unit
- Mr. Kazuaki YokoyamaExecutive Officer, Director of Marketing
- Mr. Sadayuki SenohExecutive Officer, Director of General Affairs
- Mr. Hiroshi HorinouchiDirector, since 2007
- Mr. Fumihiro NakajimaDirector, since 2017
- Ms. Atsuko OtakiIndependent Director
- Mr. Yasuyuki YoshidaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medikit Co Ltd has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation, which has been built over years of providing high-quality medical devices and equipment. This reputation enables Medikit to attract and retain customers, giving it a competitive advantage in the industry.
- Secondly, Medikit has a diverse product portfolio that caters to various medical needs. This enables the company to serve a wide range of customers and capture a larger market share. Additionally, the company's commitment to technological innovation allows it to stay ahead of competitors and offer cutting-edge solutions to its customers.
Weaknesses
- Despite its strengths, Medikit Co Ltd also faces some weaknesses that need to be addressed. Firstly, the company heavily relies on a few key suppliers for its raw materials. Any disruptions in the supply chain can potentially impact the company's production and lead to delays in fulfilling customer orders.
- Secondly, Medikit has relatively limited international presence compared to some of its competitors. This restricts its access to global markets and potential customers, thereby limiting its growth opportunities. Expanding its international reach should be a strategic priority for the company.
Opportunities
- Medikit Co Ltd operates in a growing healthcare market, presenting several opportunities for further expansion. Firstly, the increasing global demand for advanced medical devices and equipment provides a chance for the company to enter new markets and increase its customer base.
- Secondly, the rising focus on telemedicine and remote patient monitoring opens up opportunities for Medikit to develop innovative solutions in these areas. By investing in research and development, the company can create products that cater to the evolving needs of healthcare providers and patients, thereby gaining a competitive edge.
Threats
- Medikit Co Ltd operates in a highly competitive industry, which poses several threats to its market position. Firstly, the presence of well-established competitors with extensive resources and market dominance can make it challenging for Medikit to gain a significant market share.
- Additionally, changes in government regulations and policies regarding medical devices and healthcare could impact the company's operations. Compliance with regulatory requirements and adapting to any new regulations is crucial to avoid potential penalties and disruption in business operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.